Forte Biosciences, Inc. (FBRX)

Forte Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	22.24	37.13	41.1	42.04	58.77
Short-Term Investments	36.12	-	-	-	-
Cash & Short-Term Investments	58.37	37.13	41.1	42.04	58.77
Cash Growth	57.21%	-9.67%	-2.25%	-28.45%	746.88%
Prepaid Expenses	2.98	1.04	0.34	0.39	0.96
Other Current Assets	-	0.17	0.07	0.09	0.18
Total Current Assets	61.35	38.33	41.51	42.52	59.9
Property, Plant & Equipment	0.08	0.11	-	-	0.1
Long-Term Deferred Charges	-	-	-	0.11	0.29
Other Long-Term Assets	0.14	0.54	0.49	0.68	0.96
Total Assets	61.56	38.98	42	43.31	61.24
Accounts Payable	4.88	1.42	1.15	0.95	1.24
Accrued Expenses	4.2	2.24	2.03	0.81	1.02
Total Current Liabilities	9.08	3.67	3.18	1.76	2.26
Total Liabilities	9.08	3.67	3.18	1.76	2.26
Common Stock	0.01	0.04	0.02	0.02	0.01
Additional Paid-In Capital	206.46	153.79	125.84	114.7	110.42
Retained Earnings	-154	-118.52	-87.04	-73.17	-51.46
Comprehensive Income & Other	0.01	0	-	-	-
Total Common Equity	52.48	35.31	38.82	41.55	58.98
Shareholders' Equity	52.48	35.31	38.82	41.55	58.98
Total Liabilities & Equity	61.56	38.98	42	43.31	61.24
Net Cash (Debt)	58.37	37.13	41.1	42.04	58.77
Net Cash Growth	57.21%	-9.67%	-2.25%	-28.45%	746.88%
Net Cash Per Share	20.02	29.40	59.11	75.25	199.64
Filing Date Shares Outstanding	6.58	1.46	0.84	0.59	0.54
Total Common Shares Outstanding	6.39	1.45	0.84	0.59	0.51
Working Capital	52.27	34.66	38.33	40.76	57.64
Book Value Per Share	8.21	24.30	46.21	70.40	114.92
Tangible Book Value	52.48	35.31	38.82	41.55	58.98
Tangible Book Value Per Share	8.21	24.30	46.21	70.40	114.92
Machinery	-	0.12	-	-	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q